Dror Bashan
2020
In 2020, Dror Bashan earned a total compensation of $1.3M as President and Chief Executive Officer at Protalix BioTherapeutics, a 243% increase compared to previous year.
Compensation breakdown
| Bonus | $137,522 |
|---|---|
| Option Awards | $163,518 |
| Salary | $351,569 |
| Stock Awards | $579,047 |
| Other | $110,296 |
| Total | $1,341,952 |
Bashan received $579K in stock awards, accounting for 43% of the total pay in 2020.
Bashan also received $137.5K in bonus, $163.5K in option awards, $351.6K in salary and $110.3K in other compensation.
Rankings
In 2020, Dror Bashan's compensation ranked 7,342nd out of 13,090 executives tracked by ExecPay. In other words, Bashan earned more than 43.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,342 out of 13,090 | 44th |
Division Manufacturing | 3,078 out of 5,620 | 45th |
Major group Chemicals And Allied Products | 1,238 out of 2,253 | 45th |
Industry group Drugs | 1,070 out of 1,953 | 45th |
Industry Biological Products, Except Diagnostic Substances | 253 out of 411 | 38th |
Source: SEC filing on April 29, 2022.
Bashan's colleagues
We found two more compensation records of executives who worked with Dror Bashan at Protalix BioTherapeutics in 2020.
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020